Weize Li
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Traditional Chinese Medicine Analysis
- Medicinal Plants and Neuroprotection
Papers in
-
- Advanced Drug Delivery Systems 6
- Drug Solubulity and Delivery Systems 2
-
- Medicinal Plants and Neuroprotection 2
- Co-authors
- Ning Zhao (6 shared papers)Yongqiang Zhou (3 shared papers)Ting Liu (1 shared paper)Yongqiang Zhou (1 shared paper)Jianping Zhou (1 shared paper)Yong Zhang (1 shared paper)Lvyi Chen (1 shared paper)Lei Xu (1 shared paper)
In The Last Decade
Weize Li
28 papers receiving 771 citations
Peers
Comparison fields: 5 of 69
- Pharmaceutical Science 377
- Complementary and alternative medicine 97
- Biomaterials 106
- Drug Discovery 1
- Neurology 26
Countries citing papers authored by Weize Li
This map shows the geographic impact of Weize Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Li more than expected).
Fields of papers citing papers by Weize Li
This network shows the impact of papers produced by Weize Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Li. The network helps show where Weize Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Weize Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 191 | |
| 2 | 2012 | 126 | |
| 3 | 2011 | 106 | |
| 4 | 2010 | 66 | |
| 5 | 2009 | 56 | |
| 6 | 2016 | 49 | |
| 7 | 2012 | 48 | |
| 8 | 2016 | 37 | |
| 9 | 2024 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2023 | 10 | |
| 12 | 2020 | 8 | |
| 13 | 2017 | 6 | |
| 14 | 2021 | 6 | |
| 15 | 2024 | 6 | |
| 16 | 2023 | 5 | |
| 17 | 2024 | 5 | |
| 18 | LncRNA-Anrel promotes the proliferation and migration of synovial fibroblasts through regulating miR-146a-mediated annexin A1 expression. | 2023 | 4 |
| 19 | 2018 | 3 | |
| 20 | The optimization of total flavonoids from rhizoma drynariae by response surface methodology and the metal ion chelation activity assay. | 2021 | 3 |
About Weize Li
Weize Li is a scholar working on Pharmaceutical Science, Complementary and alternative medicine, Pharmacology, Organic Chemistry and Immunology, having authored 29 papers that have together received 792 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), Drug Solubulity and Delivery Systems (2 papers), Alzheimer's disease research and treatments (2 papers), Phytochemistry and Biological Activities (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Medicinal Plants and Neuroprotection (2 papers), Catalytic Cross-Coupling Reactions (2 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Pharmaceutical Science (377 citations), Complementary and alternative medicine (97 citations), Biomaterials (106 citations), Drug Discovery (1 citation) and Neurology (26 citations). Weize Li has collaborated with scholars based in China and Australia. Frequent co-authors include Ning Zhao, Yongqiang Zhou, Ting Liu, Yongqiang Zhou, Jianping Zhou, Yong Zhang, Lvyi Chen, Lei Xu, Xiao‐Ning Wang and Yongqiang Zhou. Their work appears in journals such as Environmental Toxicology and Pharmacology, European Journal of Pharmaceutical Sciences, Organic & Biomolecular Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry and Epigenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.